Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting

Abstract

is missing (Short communication)

Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large‐scale, propensity‐matched global retrospective cohort study

“…9 Although HS was previously considered an orphan disease, the newest epidemiological studies assess its prevalence at around 1% of the population; however, the exact percentage depends on the study's methodology. 9,[22][23][24] The disease usually affects young adults, most commonly shortly after adolescence, with a slightly higher prevalence among women. Its incidence declines significantly in those older than 50.…”

“…Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, and debilitating disorder of the pilosebaceous unit 9 . Although HS was previously considered an orphan disease, the newest epidemiological studies assess its prevalence at around 1% of the population; however, the exact percentage depends on the study's methodology 9,22–24 . The disease usually affects young adults, most commonly shortly after adolescence, with a slightly higher prevalence among women.…”

The NLRP3 Inflammasome Gene Is Overexpressed in Hidradenitis Suppurativa Lesions: A Preliminary Study on the Role of Pyroptosis in Disease Pathogenesis

“…HS is a chronic, recurrent, inflammatory dermatosis primarily affecting young adults, with a peak incidence in patients between 20–40 years old [ 1 ]. The exact prevalence of the disease is unknown, yet according to the latest epidemiological studies, it may vary between 0.6–2.2% [ 14 , 15 , 16 ], with almost two-fold higher prevalence among women [ 17 ]. The disease is characterized by the appearance of recurrent, slowly healing, deeply seated inflammatory nodules or abscesses, which subsequently progress into purulent inflammatory tunnels and mutilating scarring [ 1 , 18 ].…”

S2k-Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa (ICD-10-Code: L73.2)

“…Kürzlich wurde eine globale Initiative gestartet, um die Prävalenz von HS/AI weltweit anhand eines standardisierten Fragebogens zu untersuchen, gefolgt von einer ärztlich bestätigten Diagnose (www.GhiSa.org). Ein erstes Ergebnis dieser Initiative zeigte eine HS/AI-Prävalenz von 3,2 % in Grönland bei 506 Personen, was 0,9 % der grönländischen Bevölkerung entspricht [47].…”